Article
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
29 Jul 2021
Abstract excerpt
Remarkable progress has been made in the treatment and control of hepatitis B and C viral infections. However, fundamental treatments for diseases in which liver fibrosis is a key factor, such as cirrhosis, alcoholic/nonalcoholic steatohepatitis, autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, are still under development and remain an unmet medical need. To solve this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
